Seer Raises $55M in Series D Equity Financing


Seer, Inc., a Redwood City, Calif.-based life sciences company focused on capturing and translating proteome insights to advance human health, raised $55m in Series D equity financing.

The round was led by healthtech and life sciences venture capital fund aMoon, with participation from funds and accounts advised by T. Rowe Price Associates, Inc., all current investors and other new backers.

The company intends to use the funds to continue advancing its proprietary Proteographâ„¢ platform, as well as ongoing development and future commercialization efforts of proteomics products for research and clinical applications.

Founded by Omid Farokhzad, M.D., Philip Ma, Ph.D. and Robert Langer, Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights in the understanding of biology and disease.



Join the discussion